Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: Relationship to urinary loss of IgG and other factors☆
References (26)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
Ann Biochem
(1976)- et al.
Significance of anti-phospholipid antibodies in patients with lupus nephritis
Kidney Int
(1991) - et al.
Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus
- Alarcón-Segovia D, Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Characterization and classification criteria of...
- et al.
The 1982 revised criteria for the classification of systemic lupus erythematosus
Arthritis Rheum
(1982) Most commonly discontinuous buffer system for SDS electrophoresis
Nature
(1970)- et al.
Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA)
- et al.
Anticardiolipin antibodies
- et al.
Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus
- et al.
Evaluation of the anticardiolipin antibody test
IgG subclass composition of monomeric and polymeric IgG in the serum of patients with nephrotic syndrome
Clin Nephrol
Asymmetric depression in the serum level of IgG subclasses in patients with nephrotic syndrome
Clin Exp Immunol
Studies on the metabolism of plasma protein in the nephrotic syndrome. I. Albumin, gamma-globulin and iron-binding globulin
J Clin Invest
Cited by (23)
Seronegative antiphospholipid syndrome: Myth or reality?
2020, Revue de Medecine InterneControversies concerning the antiphospholipid syndrome in obstetrics
2017, Reumatologia ClinicaDoes seronegative antiphospholipid syndrome really exist?
2012, Autoimmunity ReviewsCitation Excerpt :A variety of other proteins have been implicated as targets for aPL, including prothrombin, protein C, protein S and placental anticoagulant protein. A decrease in aPL levels has been observed after the development of nephrotic syndrome, that has been attributed to urinary loss of IgG aPL, a decrease in their synthesis, and/or increase in their catabolism [29]. The aPL titles may markedly decrease during treatment with corticosteroids (i.e., for the treatment of inflammatory manifestations of associated systemic lupus erythematosus), although the correlation between prednisone treatment and aPL titles has not been definitively documented [30].
The clinical presentation of systemic lupus erythematosus
2004, Systemic Lupus Erythematosus, Fourth EditionAnticardiolipin and anti-β<inf>2</inf>-glycoprotein-I antibodies in hypertensive disorders of pregnancy
2002, Archives of Medical ResearchThe anti-phospholipid antibody syndrome: Clinical and serological aspects
2000, Bailliere's Best Practice and Research in Clinical Rheumatology
- ☆
This work was supported with grants from the Consejo Nacional de Ciencia y Tecnología, Mexico, and the “German Portilla” Fund for Investigations in Systemic Lupus Erythematosus, Mexico City, Mexico.